GIPR signaling reduces dopamine release in the brain New work from the lab
Why GLP-1 Agonists Outperform Metformin for Weight Loss Metformin was developed as a diabetes medication, not a weight loss drug, so its metabolic effects are indirect and modest
32 As previously explained, the mediator Akt is also demonstrated to activate mTOR, allowing beta cell growth through cell cycle progression and by enhancing protein synthesis
DIY Formulations: Add at 1-3% to water-based formulations
We routinely support compounding pharmacies and sterile manufacturers with audit readiness, mock inspections, and remediation, including the systems-level work that prevents exactly this kind of cascade
If you need to change the day or have missed a dose, refer to the guidelines on missed doses or contact your healthcare team